LRRCAPS as modifiers of the p53 pathway and methods of use

Details for Australian Patent Application No. 2002337914 (hide)

Owner EXELIXIS, INC.

Inventors Li, Danxi; Plowman, Gregory, D.; Francis-Lang, Helen; Funke, Roel P; Schleithoff, Lothar; Belvin, Marcia; Lioubin, Mario N; Friedman, Lori

Agent Davies Collison Cave

Pub. Number AU-A-2002337914

PCT Number PCT/US02/33540

PCT Pub. Number WO2003/035831

Priority 60/338,733 22.10.01 US; 60/357,600 15.02.02 US; 60/361,196 01.03.02 US

Filing date 21 October 2002

Wipo publication date 6 May 2003

Event Publications

20 February 2003 Complete Application Filed

  Priority application(s): 60/338,733 22.10.01 US; 60/357,600 15.02.02 US; 60/361,196 01.03.02 US

3 July 2003 Application Open to Public Inspection

  Published as AU-A-2002337914

27 April 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002337915-CTSLS AS MODIFIERS OF THE P53 AND APAF-1 PATHWAYS AND METHODS OF USE

2002337913-GLYCOSULFOPEPTIDE INHIBITORS AND METHODS OF USE THEREOF